Diabetic dyslipidemia and response to intensified glycemic treatment: why there are differences?
Baroni
M G
MG
D001059:Apoproteins / Q000235:genetics / Q000502:physiology; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D048909:Diabetes Complications / Q000097:blood / Q000209:etiology / Q000235:genetics*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000235:genetics* / Q000628:therapy*; D003927:Diet, Diabetic; D050171:Dyslipidemias / Q000097:blood / Q000209:etiology* / Q000235:genetics; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008071:Lipoprotein Lipase / Q000235:genetics / Q000502:physiology; D014280:Triglycerides / Q000097:blood
D001059:Apoproteins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D007004:Hypoglycemic Agents; D007328:Insulin; D014280:Triglycerides; D008071:Lipoprotein Lipase